Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Apr;72 Suppl 2(0 2):ii111-5.
doi: 10.1136/annrheumdis-2012-202576.

Janus kinase inhibitors in autoimmune diseases

John J O'Shea  1 , Apostolos Kontzias, Kunihiro Yamaoka, Yoshiya Tanaka, Arian Laurence
Affiliations
Review

Janus kinase inhibitors in autoimmune diseases

John J O'Shea et al. Ann Rheum Dis. 2013 Apr.

Abstract

Biological therapies directed at proinflammatory cytokines have irrevocably changed the landscape of treatment of rheumatoid arthritis (RA) and other autoimmune diseases. With the advances in our knowledge in cytokine signalling, the question emerges whether targeting intracellular signalling might also be a safe and efficacious strategy. Janus kinases or Jaks are critical for a large family of cytokines and the first Jak inhibitors has been approved by the FDA. It is therefore timely to consider this new category of drugs and reflect on their potential roles, present and future, in the treatment of RA and related disorders.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Usage of different Jaks by various cytokines
Figure 2
Figure 2. Jakinibs block multiple aspects of cytokine signaling
Cytokine binding to its cognate receptor leads to phosphorylation of the intracellular domain of the tyrosine kinase receptor by specific Jaks. STATs are then recruited, bind to the receptor and become phosphorylated by Jaks. This results in STAT dimerization, translocation, and regulation of gene transcription. Cytokines also activate the PKB (Akt) and mTOR. Though not carefully studied, it is highly likely that blocking proximal cytokine signals will disrupt all downstream pathways. ** Also referred to as AKT.
Figure 3
Figure 3
Impact of inhibiting various Jaks on signaling by selected cytokines
See this image and copyright information in PMC

References

    1. Brennan FM, McInnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest. 2008;118(11):3537–45. - PMC - PubMed
    1. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205–19. - PubMed
    1. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361(5):496–509. - PubMed
    1. Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011;365(18):1713–25. - PubMed
    1. Dougados M, Baeten D. Spondyloarthritis. Lancet. 2011;377(9783):2127–37. - PubMed

MeSH terms